Search Result "ldl"


“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses

Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos

Cholesterol and LDL Relate to Neuritic Plaques and to APOE4 Presence but Not to Neurofibrillary Tangles

Journal: Current Alzheimer Research
Volume: 8 Issue: 3 Year: 2011 Page: 303-312
Author(s): G. T. Lesser, M. S. Beeri, J. Schmeidler, D. P. Purohit, V. Haroutunian

Ox-LDL Particles: Modified Components, Cellular Uptake, Biological Roles and Clinical Assessments

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 11 Issue: 2 Year: 2011 Page: 119-128
Author(s): Mohammad Najafi, Abazar Roustazadeh, Behnam Alipoor

Cardiovascular Disease and Dyslipidemia: Beyond LDL

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 9 Year: 2011 Page: 861-870
Author(s): Janine Poss, Florian Custodis, Christian Werner, Oliver Weingartner, Michael Bohm, Ulrich Laufs

Regulation of the Urokinase Receptor (uPAR) by LDL Receptor-related Protein-1 (LRP1)

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 1 Year: 2011 Page: 1962-1969
Author(s): Steven L. Gonias, Alban Gaultier, Minji Jo

“European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary

Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 531-532
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos

Lipid Management for the Prevention of Cardiovascular Disease

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 9 Year: 2011 Page: 852-860
Author(s): Juergen R. Schaefer

Antisense Oligonucleotides for the Treatment of Dyslipidemia

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 9 Year: 2011 Page: 950-960
Author(s): I. Gouni-Berthold, H. K. Berthold

Ezetimibe and Reactive Oxygen Species

Journal: Current Vascular Pharmacology
Volume: 9 Issue: 1 Year: 2011 Page: 109-120
Author(s): Minako Yamaoka-Tojo, Taiki Tojo, Naonobu Takahira, Takashi Masuda, Tohru Izumi

Plant Sterols and Stanols in the Treatment of Dyslipidemia: New Insights into Targets and Mechanisms Related to Cardiovascular Risk

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 9 Year: 2011 Page: 922-932
Author(s): Sabine Baumgartner, Ronald P. Mensink, Jogchum Plat

Previous   Next

Go To   Results 1 - 1 of 386

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy